Equity Profile

IRTC

iRhythm Holdings, Inc.

Health CareHealth Care Equipment$3.6B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions for cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability, and investors will be looking for any signs of improvement or continued losses.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its business and capturing market share in the healthcare sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions for cardiac monitoring. Their innovative technology helps in diagnosing heart conditions, which is increasingly important as healthcare moves towards more personalized and remote care solutions. With a market cap of $4 billion, they are positioned in a growing sector focused on health care equipment.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

In Q1 2026, iRhythm reported an EPS of -$0.35, which was better than the expected -$0.56, leading to a positive market reaction with a 6.96% stock increase the following day. However, revenue details were not disclosed, leaving some uncertainty.

Management Promises & Guidance

Focus on improving customer adoption of their cardiac monitoring solutions.
Commitment to enhancing product features and user experience.
Plans to expand partnerships with healthcare providers.

Expectations

Wall Street Expectations

Overall, expectations for iRhythm's upcoming earnings are mixed, with some analysts hopeful for continued improvement in EPS and customer adoption, while others remain cautious due to the lack of revenue guidance.

Bull Case

The optimistic view hinges on the belief that iRhythm will continue to beat EPS estimates, reflecting improved operational efficiency and customer growth.

Bear Case

Conversely, the pessimistic outlook suggests that without clear revenue guidance, the company may struggle to maintain investor confidence, especially if losses continue.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current customer adoption rate for iRhythm's cardiac monitoring solutions?

This metric will be crucial in assessing the company's growth potential and market penetration, especially in a competitive healthcare landscape.

How does iRhythm plan to address ongoing losses while improving its product offerings?

Understanding management's strategy for profitability will help investors gauge the company's long-term viability and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for iRhythm's technology to gain traction in the healthcare market, especially as telehealth continues to grow.

Supporting Evidence

The recent positive EPS surprises indicate a trend of operational improvement.

The options market is pricing in a move that suggests greater volatility than historical averages, indicating potential for significant market reaction.

Management's previous commitments to enhancing product offerings could lead to unexpected revenue growth.

Key Risk

If customer adoption rates exceed expectations, it could significantly alter the market's perception of iRhythm's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether iRhythm can turn its operational improvements into tangible financial results.

Bull Confirmed If

A significant reduction in EPS losses, ideally moving towards break-even or profitability, would confirm the bull case.

Bear Confirmed If

Continued losses without a clear path to profitability would reinforce the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a potential move of about 3.3%, indicating that traders expect some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations and raises guidance, history suggests a potential stock increase of around 1.17%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction, reflecting uncertainty.

Miss

A miss on EPS could lead to a slight decline, with history suggesting minimal movement in such cases, averaging around 0.00%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on customer adoption rates for their cardiac monitoring solutions.
2Any new partnerships or collaborations with healthcare providers.
3Details on cost management strategies and plans to reduce losses.
4Insights into product enhancements and their expected impact on sales.
5Management's outlook on the competitive landscape and market opportunities.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

iRhythm Holdings, Inc. is a healthcare company that specializes in digital health solutions for cardiac monitoring....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability, and investors will be looking for any signs of improvement or continued losses.

N/A

Revenue Growth

Revenue growth indicates how well the company is expanding its business and capturing market share in the healthcare sector.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

IRTC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+209.31%

Avg Stock Reaction

+0.87%

Last Quarter Recap

Management Promises & Guidance

Focus on improving customer adoption of their cardiac monitoring solutions.
Commitment to enhancing product features and user experience.
Plans to expand partnerships with healthcare providers.

Expectations

Wall Street Expectations

Bull Case

The optimistic view hinges on the belief that iRhythm will continue to beat EPS estimates, reflecting improved operational efficiency and customer growth.

Bear Case

Conversely, the pessimistic outlook suggests that without clear revenue guidance, the company may struggle to maintain investor confidence, especially if losses continue.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the current customer adoption rate for iRhythm's cardiac monitoring solutions?

This metric will be crucial in assessing the company's growth potential and market penetration, especially in a competitive healthcare landscape.

How does iRhythm plan to address ongoing losses while improving its product offerings?

Understanding management's strategy for profitability will help investors gauge the company's long-term viability and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for iRhythm's technology to gain traction in the healthcare market, especially as telehealth continues to grow.

Supporting Evidence

The recent positive EPS surprises indicate a trend of operational improvement.

The options market is pricing in a move that suggests greater volatility than historical averages, indicating potential for significant market reaction.

Management's previous commitments to enhancing product offerings could lead to unexpected revenue growth.

Key Risk

If customer adoption rates exceed expectations, it could significantly alter the market's perception of iRhythm's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether iRhythm can turn its operational improvements into tangible financial results.

Bull Confirmed If

A significant reduction in EPS losses, ideally moving towards break-even or profitability, would confirm the bull case.

Bear Confirmed If

Continued losses without a clear path to profitability would reinforce the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±3.3%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a potential move of about 3.3%, indicating that traders expect some volatility around the earnings announcement.

Options are pricing ±3.3% while IRTC has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

48.4%

Calls (1K)P/C Ratio: 0.30Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If iRhythm beats expectations and raises guidance, history suggests a potential stock increase of around 1.17%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may experience a muted reaction, reflecting uncertainty.

Miss

A miss on EPS could lead to a slight decline, with history suggesting minimal movement in such cases, averaging around 0.00%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on customer adoption rates for their cardiac monitoring solutions.
2Any new partnerships or collaborations with healthcare providers.
3Details on cost management strategies and plans to reduce losses.
4Insights into product enhancements and their expected impact on sales.
5Management's outlook on the competitive landscape and market opportunities.